Identification of potent and selective inhibitors of PDGF receptor autophosphorylation

Journal of Medicinal Chemistry

Volumn 49, Issue 7, 2006, Pages 2186-2192

  Furuta, Takayuki ^a,b   Sakai, Teruyuki ^a   Senga, Terufumi ^a   Osawa, Tatsushi ^a   Kubo, Kazuo ^a   Shimizu, Toshiyuki ^a   Suzuki, Rika ^a   Yoshino, Tetsuya ^a   Endo, Megumi ^a   Miwa, Atsushi ^a  

^a KIRIN BREWERY CO LTD   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTHIOUREA; FUNCTIONAL GROUP; N [4 [(6,7 DIMETHOXY 4 QUINOLYL)OXY]PHENYL] N' (2 METHYLBENZOYL)THIOUREA; PLATELET DERIVED GROWTH FACTOR RECEPTOR; QUINAZOLINE DERIVATIVE; QUINOLINE DERIVATIVE; STEM CELL FACTOR RECEPTOR; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG; UREA; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; CAROTID ARTERY INJURY; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MALE; NONHUMAN; RAT; RESTENOSIS; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, ORAL; ANIMALS; CAROTID STENOSIS; CELL LINE; MALE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-KIT; QUINAZOLINES; QUINOLINES; RATS; RATS, WISTAR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP; THIOUREA;

EID: 33645685429     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0506423     Document Type: Article

References (21)

1. Iida, H.; Seifert, R.; Alpers, C. E.; Gronwald, R. G.; Phillips, P. E.; Pritzl, P.; Gordon, K.; Gown, A. M.; Ross, R.; Bowen-Pope, D. F. Johnson, R. J. Platelet-Derived Growth Factor (PDGF) and PDGF Receptor are Induced in Mesangial Proliferative Nephritis in the Rat. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 6560-6564.
2. Johnson, R. J.; Raines, E. W.; Floege, J.; Yoshimura, A.; Pritzl, P.; Alpers, C. E.; Ross, R. Inhibition of Mesangial Cell Proliferation and Matrix Expansion in Glomerulonephritis in the Rat by Antibody to Platelet-Derived Growth Factor. J. Exp. Med. 1992, 175, 1413-1416.
3. Rice, A. B.; Moomaw, C. R.; Morgan, D. L.; Bonner, J. C. Specific Inhibitors of Platelet-Derived Growth Factor or Epidermal Growth Factor Receptor Tyrosine Kinase Reduce Pulmonary Fibrosis in Rats. Am. J. Pathol. 1999, 155, 213-221.
4. Buchdunger, E.; Zimmermann, J.; Mett, H.; Meyer, T.; Muller, M.; Druker, B. J.; Lydon, N. B. Inhibition of the Abl Protein-Tyrosine Kinase in Vitro and in Vivo by a 2-Phenylaminopyrimidine Derivative. Cancer Res. 1996, 56, 100-104.
5. Heinrich, M.; Griffith, D. J.; Druker, B. J.; Wait, C. L.; Ott, K. A.; Zigler, A. J. Inhibition of c-kit Receptor Tyrosine Kinase Activity by STI 571, a Selective Tyrosine Kinase Inhibitor. Blood 2000, 96, 925-932.
6. Maguire, M. P.; Sheets, K. R.; McVety, K.; Spada, A. P.; Zilberstein, A. A New Series of PDGF Receptor Tyrosine Kinase Inhibitors: 3-Substituted Quinoline Derivatives. J. Med. Chem. 1994, 37, 2129-2137.
7. Dolle, R. E.; Dunn, J. A.; Bobko, M.; Singh, B.; Kuster, J. E.; Baizman, E.; Harris, A. L.; Sawutz, D. G.; Miller, D.; Wang, S.; Faltynek, C. R.; Xie, W.; Sarup, J.; Bode, D. C.; Pagani, E. d.; Silver, P. J. 5,7-Dimethoxy-3-(4- pyridinyl)quinoline Is a Potent and Selective Inhibitor of Human Vascular β-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase. J. Med. Chem. 1994, 37, 2627-2629.
8. Kovalenko, M.; Gazit, A.; Bohmer, A.; Rorsman, C.; Ronnstrand, L.; Heldin, C. H.; Waltenberger, J.; Bohmer, F. D.; Levitzki, A. Selective Platelet-Derived Growth Factor Receptor Kinase Blockers Reverse sis-Transformation. Cancer Res. 1994, 54, 6106-6114.
9. Bilder, G.; Wentz, T.; Leadley, R.; Leadley, R.; Amin, D.; Byan, L.; O'Conner, B.; Needle, S.; Galczenski, H.; Bostwick, J.; Kasiewski, C.; Myers, M.; Spada, A.; Merkel, L.; Ly, C.; Persons, P.; Page, K.; Perrone, M.; Dunwiddie, C. Restenosis Following Angioplasty in the Swine Coronary Artery Is Inhibited by an Orally Active PDGF-Receptor Tyrosine Kinase Inhibitor, RPR101511A. Circulation 1999, 99, 3292-3299.
10. Buchdunger, E.; Zimmermann, J.; Mett, H.; Meyer, T.; Muller, M.; Regenass, U.; Lydon, N. B. Selective Inhibition of the Platelet-Derived Growth Factor Signal Transduction Pathway by a Protein-Tyrosine Kinase Inhibitor of the 2-Phenylaminopyrimidine Class. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 2558-2562.
11. Zimmermann, J.; Buchdunger, E.; Mett, H.; Meyer, T.; Lydon, N. B.; Traxler, P. Phenylamino-pyrimidine (PAP) Derivatives: A New Class of Potent and Highly Selective PDGF-Receptor Autophosphorylation Inhibitors. Bioorg. Med. Chem. Lett. 1996, 6, 1221-1226.
12. Zimmermann, J.; Buchdunger, E.; Mett, H.; Meyer, T.; Lydon, N. B. Potent and Selective Inhibitors of the Abl-kinase: Phenylamino-pyrimidine (PAP) Derivatives. Bioorg. Med. Chem. Lett. 1997, 7, 187-192.
13. Sun, L.; Tran, N.; Liang, C.; Tang, F.; Rice, A.; Shreck, R.; Waltz, K.; Shawver, L. K.; McMahon, G.; Tang, C. Design, Synthesis, and Evaluations of Substituted 3-[(3- or 4-Carboxyethylpyrrol-2-yl)-methylidenyl]indolin-2-ones as Inhibitors of VEGF, FGF, and PDGF Receptor Tyrosine. J. Med. Chem. 1999, 42, 5120-5130.
14. Yu, J. C.; Lokker, N. A.; Hollenbach, S.; Apatira, M.; Li, J.; Betz, A.; Sedlock, D.; Oda, S.; Nomoto, Y.; Matsuno, K.; Ide, S.; Tsukuda, E.; Giese, N. A. Efficacy of Novel Selective Platelet-Derived Growth Factor Receptor Antagonist CT52923 on Cellular Proliferation, Migration, and Suppression of Neointima following Vascular Injury. J. Pharm. Exp. Ther. 2001, 298, 1172-1178.
15. Matsuno, K.; Nakajima, T.; Ichimura, M.; Giese, N. A.; Yu, J. C.; Lokker, N. A.; Ushiki, J.; Ide, S.; Oda, S.; Nomoto, Y. Potent and Selective Inhibitors of Platelet-Derived Growth Factor Receptor Phosphorylation. 1. Synthesis, Structure-Activity Relationship, and Biological Effects of a New Class of Quinazoline Derivatives. J. Med. Chem. 2002, 45, 3057-3066.
16. Pandey, A.; Volkots, D. L.; Seroogy, J. M.; Rose, J. W.; Yu, J. C.; Lambing, J. L.; Hutchaleelaha, A.; Hollenbach, S. J.; Abe, K.; Giese, N. A.; Scarborough, R. M. Identification of Orally Active, Potent, and Selective 4-Piperazinylquinazolines as Antagonists of the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Family. J. Med. Chem. 2002, 45, 3772-3793.
17. Hunter, T. Signaling-2000 and Beyond. Cell. 2000, 100, 113-127.
18. Kubo, K.; Shimizu, T.; Ohyama, S.; Murooka, H.; Nishitoba, T.; Kato, S.; Kobayashi, Y.; Yagi, M.; Isoe, T.; Nakamura, K.; Osawa, T.; Izawa, T. A Novel Series of 4-Phenoxyquinolines: Potent and Highly Selective Inhibitors of PDGF Receptor Autophosphorylation. Bioorg. Med. Chem. Lett. 1997, 23, 2935-2940.
19. Kubo, K.; Ohyama, S.; Shimizu, T.; Takami, A.; Murooka, H.; Nishitoba, T.; Kato, S.; Yagi, M.; Kobayashi, Y.; Iinuma, N.; Isoe, T.; Nakamura, K.; Iijima, H.; Osawa, T.; Izawa, T. Synthesis and Structure-Activity Relationship for New Series of 4-Phenoxyquinoline Derivatives as Specific Inhibitors of Platelet-Derived Growth Factor Receptor Tyrosine Kinase. Bioorg. Med. Chem. 2003, 77, 5117-5133.
20. Shimizu, T.; Fujiwara, Y.; Osawa, T.; Sakai, T.; Kubo, K.; Kubo, K.; Nishitoba, T.; Murooka, H.; Iwai, A.; Fukushima, K.; Yoshino, T.; Miwa, A. Orally Active Anti-Proliferation Agents: Novel Diphenylamine Derivatives as FGF-R2 Autophosphorylation Inhibitors. Bioorg. Med. Chem. Lett. 2004, 14, 875-879.
21. Jeremie, V.; Sebastien, L.; Frederic, M.; Fedor, S.; Patrice, D.; Christian, A.; Marc, L. B. Molecular Modeling of Wild-Type and D816V c-kit Inhibition Based on ATP-Competitive Binding of Ellipticine Derivatives to Tyrosine Kinases. J. Med. Chem. 2005, 48, 6194-6201.